A single-center, randomized, single blind, parallel design investigator study for finding validity items, evaluation criteria, and evaluation methods to evaluate the effect of gait rehabilitation using a rehabilitation robot(Healbot T) on walking ability for stroke patients who can walk independently or with supplementary help

Asan Medical Center0 个研究点目标入组 52 人开始时间: 待定最近更新: 2019年7月17日

试验速览

暂无简介。

•1. Stroke patients over 19 years old
•2. Patients who are able to board the Healbot T and more than FAC (Functional Ambulation Category) 2
•3. Patients who were able to walk independently before the onset of stroke
•4. Patients who wrote the agreement

•1. Patients who have serious difficulties in communication such as serious cognitive disorders or speech disorders.
•2. Patients with limited range of motion, such as the construction of joints (patients with musculoskeletal disorders, ex: pain due to arthritis)
•3. Patients who have ulcers that have bedsores, skin diseases, wounds or unhealed ulcers at the area touching cuff or harness.
•4. Patients with uncontrolled hypertension or orthostatic hypotension
•5. Patients who can not tolerate robot walking due to cardiovascular disease, heart failure, malignant disease, lung disease, nervous system disease, diabetes, etc.
•6. Patients with severe osteoporosis who are predicted to develop fractures
•7. Those who have difficulty walking because of severe deformity or pain in the legs
•8. Those who are suffering from severe mental illness, neuropathy or who are significantly less cooperative
•9. Pregnant women
•10. Patients with severe stiffness over Modified Ashworth Scale 3
•11. Patients withe tremor
•12. Those who weigh more than 100 kg
•13. Patients who heigh less than 150 cm or more than 185 cm
•14. Patients who participated in the rehabilitation robot study for stroke and were within 30 days of the end visit
•15. In addition, if the researcher judges that participation in this study is inappropriate

发起方